Portal vein hypoplasia is present in patients with biliary atresia at the time of diagnosis
Journal of Pediatric Gastroenterology and Nutrition · 2024
DOI: 10.1002/jpn3.12349 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Aitaro Takimoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology & Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Biliary Atresia, Portal Vein, Hypertension, Portal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, PHS HHS.
Abstract (Originalsprache)
Background
In patients with biliary atresia (BA), severe portal hypertension (HTN) develops even with successful bile flow restoration, suggesting an intrinsic factor driving portal HTN independent from bile obstruction. We hypothesize that patients with BA have abnormal portal vein (PV) development, leading to PV hypoplasia.
Methods
In this observational cohort study, we enrolled patients who were referred to a tertiary center from 2017 to 2021 to rule out BA. Newborns who underwent computed tomography angiogram as a clinical routine before intraoperative cholangiogram, and laparoscopic Kasai hepatoportoenterostomy. The diameter of the PV and hepatic artery (HA) were compared to the degree of liver fibrosis in the wedge biopsies. The jaundice clearance, native liver survival, and clinical portal hypertensive events, including ascites development and intestinal bleeding, were assessed.
Results
47 newborns with cholestasis were included in the cohort; 35 were diagnosed with BA. The patients with BA had a smaller median PV diameter (4.3 vs. 5.1 mm; p < 0.001) and larger median HA diameter (1.4 vs. 1.2 mm; p < 0.05) compared to the patients with other forms of cholestasis. The median PV and HA diameter did not correlate with the degree of liver fibrosis. Among 35 patients with BA, 29 patients (82.9%) achieved jaundice clearance, and 23 patients (65.7%) were alive with their native liver at two years of age. Seven patients (20%) developed intestinal bleeding, and seven patients (20%) developed ascites, with one overlapping patient.
Conclusion
PV hypoplasia is present in patients with BA independent of liver fibrosis at the time of diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology & Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Pediatrics, Collage of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
ORCID-Profile: Aitaro Takimoto, Akihiro Asai
Förderung
- NIDDK NIH HHS
- PHS HHS
Zitieren
APA
Takimoto, A., Wolfe, N., Jiahui, L., Kato, D., Yasui, A., Uchida, H., & Asai, A. (2024). Portal vein hypoplasia is present in patients with biliary atresia at the time of diagnosis. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12349
Vancouver
Takimoto A, Wolfe N, Jiahui L, Kato D, Yasui A, Uchida H, et al. Portal vein hypoplasia is present in patients with biliary atresia at the time of diagnosis. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12349
BibTeX
@article{Takimoto2024,
author = {Takimoto, Aitaro and Wolfe, Nicholas and Jiahui, Liu and Kato, Daiki and Yasui, Akihiro and Uchida, Hiroo and Asai, Akihiro},
title = {Portal vein hypoplasia is present in patients with biliary atresia at the time of diagnosis},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2024},
doi = {10.1002/jpn3.12349}
}
EUVIMED